RPG Life Sciences Ltd. share price target

RPG Life Sciences RPGLS (part of RPG Group) is a pharmaceutical company that operates in the domestic and international markets in the branded formulations, global generics and synthetic APIs space. The company produces a...

About the company- RPG Life Sciences RPGLS (part of RPG Group) is a pharmaceutical company that operates in the domestic and international markets in the branded formulations, global generics and synthetic APIs space. The company...

FY23 a milestone year with revenue/EBITDA of Rs 500mn/100mn; Naprosyn brand crossed Rs 500mn

EBITDA margin up 10ppt from FY19 levels to ~20% in FY22 as efforts to improve operational efficiency pay off

RPGL reported revenue growth, margin expansion and debt reduction in FY21 despite Covid-led disruptions in the acute portfolio

We recently met the management of RPG Life sciences (RPG). RPG is primarily engaged in manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs or bulk actives). RPG specializes in therapeutic areas like nephrology, oncology, urology, gastroenterology, pain management and nutritionals. RPG enjoys a strong brand recognition in anti-diarrheal, antacid, iron-vitamin, and nephrology segments. Domestic formulation 19% revenue growth YoY RPG has its manufacturing facilities in 1) Maharashtra and 2) Gujarat. RPG continues to strive to be a dominant player in specialty by focusing on differentiated products....

RPG Life Sciences Ltd (RPG), formally known as Searle India was incorporated in 1968 as a pharmaceuticals and agrochemicals business, however, divested the agrochemicals in 2001 and renamed as RPG Phamaceuticals Ltd, HQ in Mumbai which is primarily engaged in manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs or bulk actives). RPG specializes in therapeutic areas like nephrology, oncology gastroenterology, pain management and nutritionals. RPG is ranked 66th (Source: Pharmatrac) in the domestic formulations market and ranks among the top 5 Indian companies in the renal therapy segment. Domestic market accounts for ~67% of revenues while the main:specialty ratio is at 60:40. The company has...

BUY RPG Life Sciences at CMP Rs.469 and add on Declines to Rs.435 - 408 for sequential target of Rs. 545, 658

RPG Life Sciences Ltd. is an integrated Pharmaceutical Company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation API's space. The Company is a research based Pharmaceutical Company, producing a wide range of quality, affordable medicines and exports to Europe, Latin America, Canada and South East Asian Countries. In Q1FY14, the Company's turnover witnessed yoy growth of 15 percent to touch...